Immunotech Biopharm Ltd (HKG:6978)

Hong Kong · Delayed Price · Currency is HKD

0.3550

-0.0100 (-2.74%)

Jul 31, 2026, 3:42 PM HKT

-91.26% (1Y)

Market Cap	219.21M -89.5%
Revenue (ttm)	n/a
Net Income	-256.82M
EPS	-0.47
Shares Out	617.50M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	87,000
Open	0.3650
Previous Close	0.3650
Day's Range	0.3450 - 0.3650
52-Week Range	0.3300 - 5.8300
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Immunotech Biopharm

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that has completed Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia that is in Phase II/III clinical trial; 6B... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2006

Employees 183

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6978

Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements